secwatch.observer — SEC 8-K summary
======================================

Issuer:     Autonomix Medical, Inc. (AMIX)
CIK:        0001617867
Form:       8-K
Filed at:   2024-10-28T23:59:59+00:00
Accession:  0001437749-24-032175
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Autonomix Medical to effect 1-for-20 reverse stock split effective Oct 24, 2024
-------------------------------------------------------------------------------

- Stockholders approved reverse split ratio range 1:2 to 1:50; board selected 1:20.
- Reverse split effective 11:59 pm ET Oct 24, 2024; Nasdaq trading post-split begins Oct 25 under AMIX.
- Outstanding shares reduce from ~23.0 million to ~1.15 million; authorized shares remain 500 million.
- No fractional shares issued; holders of fractional shares will receive rounding up to nearest whole share.
- Proportionate adjustments to exercise prices and shares for options, warrants, and convertible notes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1617867/000143774924032175/0001437749-24-032175-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1617867/000143774924032175/amix20241027_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-032175

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer